The market suffered a small correction this week but the underlying trend remains bullish. We expect a short rally next week before a deeper decline.
New Delhi: Sun Pharma Advanced Research Company Ltd on Monday said its net loss widened to Rs 81.99 crore in the fourth quarter ended March 2023, impacted by higher expenses. The company had ...
The $50 billion sector is under the spotlight after a number of recent scandals linked to smaller, privately-held Indian ...
US inspectors have in recent months uncovered wide-ranging lapses at factories run by some of India’s biggest pharmaceutical firms, as the world’s top supplier of cheap medicine faces increased ...
Most analysts remain positive on Sun Pharmaceutical ... import alert and Mohali non-compliance. Ilumya, Winlevi, and Cequa will drive growth for the specialty business in FY24/25. Deuruxolitinib will ...
Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter ...
Sun recently acquired Concert Pharmaceuticals for an upfront payment of $576 million. A possible unknown integration cost of Concert Pharma acquisition could surprise Q4 earnings negatively, Phillip ...
The company's specialty business is likely to post double-digit growth YoY in the quarter, despite some sequential moderation ...
Wegmans has recalled its Italian Classics Diavolo Pasta Sauce sold in Virginia stores over an allergy alert. It may contain anchovies, the FDA said. (USDA) VIRGINIA — The Wegmans grocery chain ...
FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's (NASDAQ: ICPT) Ocaliva 25 mg, also known as Obeticholic ...
FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's (NASDAQ:ICPT) Ocaliva 25 mg, also known as Obeticholic ...
(RTTNews) - Centessa Pharmaceuticals plc (CNTA) announced the FDA has granted Fast Track designation to SerpinPC, an investigational inhibitor of activated protein C being developed for the ...
